TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3134518

Group type: EXPERIMENTAL
Intervention: Metoprolol (beta-blocker)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (beta-blocker)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exercise (450 kpm/min followed by 600 kpm/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Long-term antihypertensive treatment
Number of subjects: 12
Study: 30144146

Group type: EXPERIMENTAL
Intervention: Low Oral Health Literacy (OHL) defined as BREALD-30 ≤ 21
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Low Oral Health Literacy (OHL)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Higher Oral Health Literacy (OHL)
Number of subjects: 344
Study: 28795232

Group type: EXPERIMENTAL
Intervention: Modified hemi-split Doyle splint (Group 2)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional Doyle intranasal silicone splint (Group 1)
Number of subjects: 64
Study: 24580835

Group type: COMPARATOR
Intervention: Flap technique (control group)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Flapless technique (test group)
Number of subjects: 34
Study: 24002152

Group type: EXPERIMENTAL
Intervention: Topical adapalene 0.1% gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical benzoyl peroxide 2.5% gel
Number of subjects: 60
Study: 21359582

Group type: EXPERIMENTAL
Intervention: Insulin-based treatment
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Insulin during hospitalisation followed by conventional glucose control (group 2)
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Conventional treatment (group 3)
Number of subjects: 1253

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1253
Study: 18191771

Group type: EXPERIMENTAL
Intervention: Psychosocial educational intervention (four 2-hour sessions focused on communication, stress appraisal, adaptive coping strategies, and building social support)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Supportive phone calls to PLWH alone (control group)
Number of subjects: 84
Study: 17007184

Group type: EXPERIMENTAL
Intervention: Radical ethmoidectomy (nasalisation)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Functional ethmoidectomy
Number of subjects: 76
Study: 14594526

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg for 20 weeks
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg for 12 weeks followed by 45 mg for 8 weeks
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg for 20 weeks
Number of subjects: 234
Study: 10918402

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose level I (60/30 mg/kg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose level II (120/60 mg/kg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose level III (120/90 mg/kg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose level IV (120/120 mg/kg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose levels I and II
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose levels III and IV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose levels I-II
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet at dose levels III-IV
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Foscarnet (all dose levels)
Number of subjects: 20
Study: 9013007

Group type: EXPERIMENTAL
Intervention: Duplex surveillance
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clinical follow-up
Number of subjects: 100
Study: 1395658

Group type: EXPERIMENTAL
Intervention: Acidified enteral feedings (pH 3.5)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Regular feedings into the stomach (pH 4.7)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Regular feedings into the duodenum (pH 3.8)
Number of subjects: 23
Study: 3911735

Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide plus 5 mg amiloride (HCTZ/A)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide plus 26 mmol potassium chloride (HCTZ/K)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HCTZ/K (double dose: 100 mg/52 mmol)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HCTZ/A (double dose: 100 mg/10 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both drug combinations
Number of subjects: 18

Group type: COMPARATOR
Intervention: HCTZ/A
Number of subjects: 18
Study: 28318688

Group type: EXPERIMENTAL
Intervention: PKU type meal
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control meal (ordinary meal and protein-enriched milk)
Number of subjects: 23
Study: 27707828

Group type: EXPERIMENTAL
Intervention: Usual care + enhanced rehabilitation package (including six additional home-based physiotherapy sessions, novel information workbook, and goal-setting diary)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Usual care + enhanced rehabilitation package
Number of subjects: 62
Study: 25001475

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C (TTM33; n = 71)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Targeted temperature management at 36 °C (TTM36; n = 68)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Targeted temperature management at 33 °C (TTM33)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Targeted temperature management at 36 °C (TTM36)
Number of subjects: 139
Study: 22515908

Group type: EXPERIMENTAL
Intervention: 5% EDTA
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 5% EDTA + 0.25% cetrimide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 5% EDTA + 0.50% cetrimide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 0.25% cetrimide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 0.50% cetrimide
Number of subjects: 25
Study: 21207919

Group type: EXPERIMENTAL
Intervention: 5% potassium nitrate dentifrice
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5% NovaMin dentifrice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-desensitizing dentifrice
Number of subjects: 30
Study: 18504760

Group type: EXPERIMENTAL
Intervention: Gadobutrol (1.0 mmol Gd/mL, 15 mL)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Gadoterate (0.5 mmol Gd/mL, 30 mL)
Number of subjects: 52
Study: 15995262

Group type: EXPERIMENTAL
Intervention: Single-leg heel raises
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Double-leg heel raises
Number of subjects: 16

Group type: COMPARATOR
Intervention: External resistance (+5% of body weight)
Number of subjects: 16

Group type: COMPARATOR
Intervention: External resistance (+10% of body weight)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No external resistance
Number of subjects: 16
Study: 14560166

Group type: EXPERIMENTAL
Intervention: Psychoeducational parenting program (3 weekly sessions + 1-month booster)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 222
Study: 10788201

Group type: EXPERIMENTAL
Intervention: Students for Peace intervention (multi-component violence-prevention program)
Number of subjects: 2246

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2246
Study: 8898462

Group type: EXPERIMENTAL
Intervention: Praziquantel (40 mg/kg body weight)
Number of subjects: 436

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 436
Study: 1716644

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (100 mg PO)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (Org 10172 IV bolus injection of 3250 anti‐Xa units)
Number of subjects: 6
Study: 6348123

Group type: EXPERIMENTAL
Intervention: Tetracycline HCl (1 gm/day for 14 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 31302899

Group type: EXPERIMENTAL
Intervention: Erenumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: OnabotulinumtoxinA
Number of subjects: 0
Study: 28333351

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (dosage not specified) administered from day 0 to day 14
Number of subjects: 48
Study: 26393396

Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI (dietary index)
Number of subjects: 6435

Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI in subjects with moderate energy intake (≤median)
Number of subjects: 6435

Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI in subjects with higher energy intake
Number of subjects: 6435

Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI and breast cancer risk
Number of subjects: 6435

Group type: EXPERIMENTAL
Intervention: FSA‐NPS DI and prostate cancer risk
Number of subjects: 6435
Study: 24268209

Group type: EXPERIMENTAL
Intervention: Bivalirudin (0.75 mg/kg bolus followed by 1.75 mg/kg/hour infusion for ≥30 minutes prior to PCI and continued for ≥4 hours at 0.25 mg/kg/hour)
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Standard-of-care anticoagulation (heparins at guideline-recommended doses, with or without glycoprotein IIb/IIIa inhibitors)
Number of subjects: 2200
Study: 21251384

Group type: EXPERIMENTAL
Intervention: Intervention group (n=41) - near- and middle-vision activities less than 30 hrs/week, more outdoor activities than 14-15 hrs/week
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n=39) - standard activities without specified restrictions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intervention group (n=41)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All children in the study
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n=39)
Number of subjects: 80
Study: 19118789

Group type: EXPERIMENTAL
Intervention: Passive static stretching (SS)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Contract-relax PNF (CRPNF) stretching
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Passive static stretching (SS) and Contract-relax PNF (CRPNF) stretching
Number of subjects: 28
Study: 17965934

Group type: EXPERIMENTAL
Intervention: Self-selected relaxing music
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 56

Group type: COMPARATOR
Intervention: Heavy metal music
Number of subjects: 56

Group type: COMPARATOR
Intervention: Silence
Number of subjects: 56
Study: 15467626

Group type: EXPERIMENTAL
Intervention: Functional suprahyoid neck dissection (FSHD)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Classical suprahyoid neck dissection (CSHD)
Number of subjects: 36
Study: 15377585

Group type: EXPERIMENTAL
Intervention: EEG power spectral frequencies from >35 Hz up to 127 Hz
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low frequencies (<15 Hz)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High frequencies (>26 Hz)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Frequency band between 15 and 26 Hz
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Power-line frequency (50 Hz) and its harmonics, 78 Hz
Number of subjects: 39
Study: 9895019

Group type: EXPERIMENTAL
Intervention: Glu/Ex
Number of subjects: 6

Group type: COMPARATOR
Intervention: No Glu/Ex
Number of subjects: 6
Study: 7717498

Group type: EXPERIMENTAL
Intervention: 2% lignocaine gel
Number of subjects: 84

Group type: COMPARATOR
Intervention: Lubafax gel (Control)
Number of subjects: 84
Study: 2030413

Group type: EXPERIMENTAL
Intervention: Modular instruction
Number of subjects: 49

Group type: COMPARATOR
Intervention: Didactic instruction
Number of subjects: 49
Study: 7225490

Group type: EXPERIMENTAL
Intervention: Eyes-open rotational vestibular stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control contact
Number of subjects: 18
Study: 30577714

Group type: EXPERIMENTAL
Intervention: Early intervention (FAN program)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 54
Study: 28573499

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard/low-dose statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study: 26954484

Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE) 1200 mg daily for 4 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 25084009

Group type: EXPERIMENTAL
Intervention: ice‐slush with menthol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: cold with menthol
Number of subjects: 12

Group type: COMPARATOR
Intervention: neutral with menthol
Number of subjects: 12
Study: 23083313

Group type: EXPERIMENTAL
Intervention: $5 incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: No incentive
Number of subjects: 0
Study: 18839306

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 59
Study: 17616771

Group type: EXPERIMENTAL
Intervention: 240 mg Salacia oblonga extract
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 480 mg Salacia oblonga extract
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 66
Study: 15078396

Group type: EXPERIMENTAL
Intervention: PACs triggering AF
Number of subjects: 108

Group type: COMPARATOR
Intervention: PACs not triggering AF
Number of subjects: 108

Group type: COMPARATOR
Intervention: PACs in healthy controls
Number of subjects: 108
Study: 12503274

Group type: EXPERIMENTAL
Intervention: Losec, 40 mg (omeprazole)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: famotidine, 80 mg (Quamatel)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Phosphalugel
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study: 9793352

Group type: EXPERIMENTAL
Intervention: Intrapleural analgesia with 75 mg of bupivacaine 0.50% administered through a peridural catheter at 8-hour intervals for up to three times
Number of subjects: 50
Study: 7543323

Group type: EXPERIMENTAL
Intervention: Interstitial laser coagulation (ILC or LITT; laser‐induced interstitial thermotherapy)
Number of subjects: 239
Study: 31997577

Group type: COMPARATOR
Intervention: Control condition (CONT): seated for 1 hour at a relative humidity (RH) of 40%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dry condition (DRY): seated for 1 hour at a RH of 20%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Exercise condition (EXER): seated for 40 minutes followed by 20 minutes of cycling exercise at a RH of 20%
Number of subjects: 12
Study: 30942010

Group type: EXPERIMENTAL
Intervention: Preoperative electroacupuncture intervention at Baliao point 30 min before PPH
Number of subjects: 60

Group type: COMPARATOR
Intervention: Simple operation group (control)
Number of subjects: 60
Study: 28625445

Group type: EXPERIMENTAL
Intervention: Pecs block with levobupivacaine 0.25%
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo block with saline
Number of subjects: 140
Study: 25611228

Group type: EXPERIMENTAL
Intervention: pemetrexed-carboplatin-bevacizumab
Number of subjects: 939

Group type: COMPARATOR
Intervention: paclitaxel-carboplatin-bevacizumab
Number of subjects: 939
Study: 23138261

Group type: EXPERIMENTAL
Intervention: Haloperidol 0.5 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Haloperidol 1 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Haloperidol 3 mg
Number of subjects: 8
Study: 20642580

Group type: EXPERIMENTAL
Intervention: CLA 4.5 g/day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 17419879

Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE) in capsule form (1.3 grams of PSE/day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 16299195

Group type: EXPERIMENTAL
Intervention: Trendelenburg tilt at 10 degrees
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trendelenburg tilt at angles greater than 10 degrees (15, 20, 25, and 30 degrees)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Trendelenburg tilt cumulative effects
Number of subjects: 20
Study: 12117878

Group type: EXPERIMENTAL
Intervention: Obesity (body mass index > or = 30 kg/m(2))
Number of subjects: 89835

Group type: COMPARATOR
Intervention: Control (postmenopausal women)
Number of subjects: 89835

Group type: COMPARATOR
Intervention: Entire cohort (all women)
Number of subjects: 89835
Study: 10430341

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal banding ligation (EVL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sclerotherapy (EVS)
Number of subjects: 100
Study: 9419519

Group type: EXPERIMENTAL
Intervention: Spiral CT with 150 ml diatrizoate meglumine
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Spiral CT with 75 ml diatrizoate meglumine
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Spiral CT with 100 ml diatrizoate meglumine
Number of subjects: 131

Group type: COMPARATOR
Intervention: Dynamic CT with 150 ml diatrizoate meglumine
Number of subjects: 131
Study: 2098573

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 100 mg twice a day for three months
Number of subjects: 4

Group type: COMPARATOR
Intervention: No flurbiprofen (control)
Number of subjects: 4
Study: 7024383

Group type: EXPERIMENTAL
Intervention: CPAP by face-mask for 4 hours after surgery
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no CPAP)
Number of subjects: 24
Study: 30718622

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (5 × 60 min/weekly for 12 weeks)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (unaltered lifestyle during 12 weeks)
Number of subjects: 170
Study: 28716081

Group type: EXPERIMENTAL
Intervention: Telenursing (TN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 0
Study: 25646406

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (70μg/2800 IU cholecalciferol daily for 52 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Surgical cure (parathyroidectomy)
Number of subjects: 46
Study: 24421408

Group type: EXPERIMENTAL
Intervention: Barbed sutures (V‐Loc, Covidien)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Smooth absorbable sutures (control)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Rapid-absorbing barbed suture
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Slow-absorbing barbed suture
Number of subjects: 229
Study: 21879101

Group type: EXPERIMENTAL
Intervention: Regular coffee (130 mg caffeine)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Double-espresso coffee
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Encapsulated caffeine (134 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo-control capsule
Number of subjects: 12
Study: 19643497

Group type: EXPERIMENTAL
Intervention: Aspheric intraocular lens (SN60WF, Alcon)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Spherical intraocular lens (SN60AT, Alcon)
Number of subjects: 26
Study: 17365766

Group type: EXPERIMENTAL
Intervention: EHR-generated practice feedback
Number of subjects: 19

Group type: COMPARATOR
Intervention: No feedback (control)
Number of subjects: 19
Study: 15716246

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention (medical, physiotherapy, and occupational therapy)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 313
Study: 12377836

Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study) with technician setup (group 1)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study) with patient's own setup (group 2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Limited sleep‐recording device (home study)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Limited sleep‐recording device vs. polysomnography
Number of subjects: 55

Group type: COMPARATOR
Intervention: Home study-derived parameters
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Home sleep studies
Number of subjects: 55
Study: 9787982

Group type: EXPERIMENTAL
Intervention: Azelastine eye drops
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Levocabastine eye drops
Number of subjects: 113
Study: 7540938

Group type: EXPERIMENTAL
Intervention: New screening technologies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening approaches
Number of subjects: 0
Study: 2692792

Group type: EXPERIMENTAL
Intervention: Off‐Axis photoscreener
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Otago photoscreener
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Off‐Axis photoscreener (younger children 24 months or less)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Otago photoscreener (younger children 24 months or less)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Both techniques with pupil dilated
Number of subjects: 236
Study: 336175

Group type: EXPERIMENTAL
Intervention: Vincristine, dactinomycin, and cyclophosphamide (VAC) for 2 years
Number of subjects: 423

Group type: COMPARATOR
Intervention: Vincristine plus dactinomycin for 1 year with postoperative irradiation
Number of subjects: 423

Group type: EXPERIMENTAL
Intervention: Intensive 'pulse' VAC or 'pulse' VAC plus Adriamycin with radiation after 6 weeks
Number of subjects: 423

Group type: COMPARATOR
Intervention: Intensive 'pulse' VAC or 'pulse' VAC plus Adriamycin
Number of subjects: 423
Study: 31852579

Group type: EXPERIMENTAL
Intervention: 3-month oxaliplatin and 5-fluorouracil or oxaliplatin and capecitabine
Number of subjects: 6088

Group type: COMPARATOR
Intervention: 6-month oxaliplatin and 5-fluorouracil or oxaliplatin and capecitabine
Number of subjects: 6088

Group type: COMPARATOR
Intervention: 6-month treatment
Number of subjects: 6088

Group type: EXPERIMENTAL
Intervention: 3-month treatment
Number of subjects: 6088
Study: 30250407

Group type: EXPERIMENTAL
Intervention: Experimental occupational therapy (OT) intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care (task‐oriented rehabilitation)
Number of subjects: 40
Study: 26865854

Group type: EXPERIMENTAL
Intervention: ABT 160 mg + LPV/r
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ABT 320 mg + LPV/r
Number of subjects: 20
Study: 24881208

Group type: EXPERIMENTAL
Intervention: Presurgical nasoalveolar molding (PNAM) treatment prior to operation in group A
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (untreated) in group B
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (normally developed nose and lip palate infants) in group C
Number of subjects: 57